bis(4-nitrophenyl)phosphate has been researched along with ascorbic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bachurin, SO; Boltneva, NP; Burgart, YV; Chupakhin, ON; Kovaleva, NV; Lushchekina, SV; Makhaeva, GF; Richardson, RJ; Rudakova, EV; Saloutin, VI; Serebryakova, OG; Shchegol'kov, EV | 1 |
Beloglazkin, AA; Boltneva, NP; Borisov, RS; Kulikova, LN; Lushchekina, SV; Makhaeva, GF; Richardson, RJ; Rudakova, EV; Serebryakova, OG | 1 |
Bachurin, SO; Boltneva, NP; Burgart, YV; Elkina, NA; Khudina, OG; Lushchekina, SV; Makhaeva, GF; Richardson, RJ; Rudakova, EV; Saloutin, VI; Serebryakova, OG; Shchegolkov, EV | 1 |
Bachurin, SO; Boltneva, NP; Burgart, YV; Elkina, NA; Kovaleva, NV; Lushchekina, SV; Makhaeva, GF; Palyulin, VA; Radchenko, EV; Richardson, RJ; Rudakova, EV; Saloutin, VI; Serebryakova, OG; Shchegolkov, EV; Stupina, TS; Terentiev, AA | 1 |
4 other study(ies) available for bis(4-nitrophenyl)phosphate and ascorbic acid
Article | Year |
---|---|
Synthesis, molecular docking, and biological activity of polyfluoroalkyl dihydroazolo[5,1-c][1,2,4]triazines as selective carboxylesterase inhibitors.
Topics: Animals; Carboxylesterase; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Structure-Activity Relationship; Triazines | 2017 |
Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
Topics: Acetylcholinesterase; Alzheimer Disease; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Chromones; Humans; Kinetics; Molecular Docking Simulation; Protein Structure, Tertiary; Structure-Activity Relationship | 2018 |
Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers.
Topics: Antioxidants; Carboxylesterase; Humans; Molecular Docking Simulation | 2019 |
Novel potent bifunctional carboxylesterase inhibitors based on a polyfluoroalkyl-2-imino-1,3-dione scaffold.
Topics: Animals; Carboxylic Ester Hydrolases; Cells, Cultured; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2021 |